"do not overinflate"
Why should we believe you that these valuations are overinflated as opposed to some author who has spent some time thinking about them. Admittedly by someone who got some calls wrong but who probably took a very considered methodology based on the facts at the time. Do not forget biotechs are a 1 in 10 proposition (except may be for this).
Going by my estimates the 60c figure is way under what I think is plausible. I am backing this and a higher valuation a responsible amount of money.
Useless Valuation Van Leeuwenhoeck Institute initiates Research Coverage, page-28
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |